Clinical Trials Logo

Eye Injuries clinical trials

View clinical trials related to Eye Injuries.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05771467 Completed - Eye Injuries Clinical Trials

Evaluation of Retinal Microvascular Change That May Develop in Patients After Open Globe İnjury With Optical Coherence Tomography (OCTA)

Start date: March 6, 2023
Phase:
Study type: Observational [Patient Registry]

The aim of this study is to evaluate posterior segment changes in the non-traumatic eye after open globe injury.

NCT ID: NCT05618522 Completed - Clinical trials for Acute Chemical Eye Injuries

Omnigen in Acute Chemical Eye Injuries

Omnigen
Start date: July 1, 2021
Phase: N/A
Study type: Interventional

evaluation of the role of Omnigen in acute chemical eye injuries

NCT ID: NCT04837534 Completed - Amblyopia Clinical Trials

Improving the Follow up Rate for Pediatric Patients

Start date: February 15, 2021
Phase: N/A
Study type: Interventional

Follow-up of pediatric patients is important for their regular ocular morbidity monitoring, especially for amblyopia management. An observatory data of 1st week (1st to 7th) of January 2019 revealed that the follow-up compliance was very low (22%) among children aged 0-16 years in the pediatric department of Bharatpur Eye Hospital. A problem tree analysis showed a lack of awareness in children and their parents regarding the importance of follow-up and patients forgetting regarding the follow-up visit, usually when there is the long duration of follow up are the major contributing factors for poor adherence to follow-up. So, an intervention study was aimed at finding the effectiveness of counseling and reminders through SMS and phone calls to improve the follow-ups. All pediatric patients 0-16 years of age with ocular conditions requiring at least 3 follow-ups in the study period (January 2021 to April 2021) will be included. Two hundred and sixty-four participants will be equally distributed to three groups: routine standard care, counseling, and reminders with SMS and phone calls. In the routine care group, children will undergo routine care as per existing practice in the hospital and there will be no additional intervention. In counseling group, in addition to routine care parents/guardians along with the child will receive counseling from a trained counselor as per the set counseling protocol in every follow-up visits and will also be provided with the disease-specific information leaflets as additional information material before the child is discharged from the department. In the SMS and phone call reminder group, in addition to routine care, parents/guardians of children will receive reminders through short messaging text (SMS) 3 days and phone calls one day prior to the scheduled visit. Compliance to follow up Participants completing all the three follow-up visits as per the schedule within the window period of +/-2 days will be considered as a complaint to follow up. However, the follow-ups of all the participants will be recorded although that is beyond the window period. The primary outcome will be measured by the proportion of children completing all three scheduled follow-ups. The ethical approval has been obtained from the Institutional Review Committee of NHRC (ERB protocol registration number 761/2020 P). Informed consent will be taken from parent and child. Conclusion: If interventions improve the follow-up rate and are cost-effective, this can be applied in all the departments of the hospital.

NCT ID: NCT04595357 Completed - Eye Injuries Clinical Trials

"Iris Shelf" Technique for Intraocular Foreign Bodies Removal

Start date: January 1, 2016
Phase:
Study type: Observational

Intraocular foreign body (IOFB) injury is a common potentially serious form of ocular trauma. Metallic IOFB is the most common type of IOFB injury. Apart from the associated ocular tissue damage, Metallic IOFB may cause permanent visual impairment due to retinal toxicity and endophthalmitis. When presenting posteriorly, the approach of IOFB removal is challenging. Several techniques had been described for posterior IOFB removal. All of these techniques aimed to remove IOFB with the least possible collateral damage. This study aims to describe "Iris shelf" technique for posterior IOFB removal through a clear corneal incision combined with phaco-vitrectomy and report its outcomes.

NCT ID: NCT04497896 Completed - Eye Trauma Clinical Trials

Playtime Open Globe Injuries in Children

Start date: January 1, 2016
Phase:
Study type: Observational

This study investigated the epidemiology, aetiologies, and complications of playtime open-globe injuries in children at the Assiut University Hospital, Egypt, between January to July 2016.

NCT ID: NCT02873026 Completed - Eye Injury Trauma Clinical Trials

Adjunctive Steroid Combination in Ocular Trauma (ASCOT) Study

ASCOT
Start date: October 2014
Phase: Phase 3
Study type: Interventional

Eye trauma is a leading cause of blindness and visual impairment. Penetrating injuries of the eye are more likely to result in poor vision and the main cause of this is a scarring response on the retina (proliferative vitreoretinopathy, PVR) The purpose of this study is to investigate the potential of an anti-inflammatory treatment (triamcinolone acetonide) to improve the outcome of surgery in eyes that have suffered severe trauma.There is good evidence from laboratory studies that additional steroid treatment into and around the eye at the time of surgery could reduce scarring by reducing inflammation and improve visual outcomes.

NCT ID: NCT02638025 Completed - Eye Injuries Clinical Trials

Anterior Segment Spectral-domain Optical Coherence Tomography in Patients With Closed Globe Injury

Start date: January 2010
Phase: N/A
Study type: Observational

This study use anterior segment spectral-domain optical coherence tomography (SD-OCT) to exam patients with closed globe injury, and compared with slit lamp examination. The results showed that OCT can identify features of closed globe injury that were otherwise not visible on slit lamp biomicroscopy.

NCT ID: NCT01490593 Completed - Eye Injuries Clinical Trials

Canadian Eye Injury Registry

CEIR
Start date: March 2, 2011
Phase: N/A
Study type: Observational

The purpose of this study is to establish an eye injury registry to assess the mechanisms and outcomes of significant eye injuries occurring in Canada. The epidemiologic data will determine where public health strategies should be directed to prevent future eye injuries.

NCT ID: NCT00598299 Completed - Eye Injuries Clinical Trials

Comparison of the Effects on Promoting Corneal Epithelial Wound Healing Between Human Auto-Serum and Cord Blood Serum

Start date: April 2007
Phase: N/A
Study type: Observational

Human serum eye drops have been successfully used in the treatment of severe ocular surface disorders and the enhancement of corneal wound healing. Umbilical cord serum is also proven to be effective in treatment of dry eye and persistent corneal epithelial defects. However, there are limited studies comparing the corneal epithelial wound healing promoting effects between these two blood derived products. The purpose of this study is to test the corneal epithelial wound healing promoting effects between auto serum and human cord blood serum. Primary cultured bovine corneal epithelial cells were used as the model to investigate wound healing, cell proliferation and migration by means of scratch corneal wound healing assay evaluation, MTS assay and Boyden chamber migration assay in response to human serum and umbilical cord serum. The concentrations of EGF, TGF-β1, and fibronectin were also compared between human serum and umbilical cord serum with ELISA kits.

NCT ID: NCT00129077 Completed - Critically Ill Clinical Trials

Does the Use of a Moisture Chamber Decrease the Incidence of Corneal Abrasions in Critically Ill Pediatric Patients?

Start date: March 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to identify the incidence of scratches on the surface of the eye in children who cannot blink due to medication use and to identify how best to reduce the risk of a scratch on the surface of the eye when patients are using specific medicines.